Best Momentum Stock to Buy for October 10th

Here is a stock with buy rank and strong momentum characteristics for investors to consider today, October 10th:

Spero Therapeutics SPRO: This multi-asset, clinical-stage biopharmaceutical company which is focused on identifying, developing and commercializing novel treatments for multi-drug resistant bacterial infections, has a Zacks Rank #1 (Strong Buy), and witnessed the Zacks Consensus Estimate for its current year earnings increasing 44.8% over the last 60 days.

Spero Therapeutics, Inc. Price and Consensus

Spero Therapeutics, Inc. price-consensus-chart | Spero Therapeutics, Inc. Quote

Spero Therapeutics' shares gained 293.3% over the last six months compared with the S&P 500’s gain of 25.6%. The company possesses a Momentum Score of B.

Spero Therapeutics, Inc. Price

Spero Therapeutics, Inc. price | Spero Therapeutics, Inc. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Zacks' Research Chief Picks Stock Most Likely to "At Least Double"

Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research